top of page

MYLOTARG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 5MG/VIAL

Product details

Registration number: SIN16243P

Classification: Prescription Only

Active ingredients: Gemtuzumab Ozogamicin

Strength: 5.0 mg/vial

Dosage form: POWDER, FOR SOLUTION

Route: INTRAVENOUS

Registrant: PFIZER PRIVATE LIMITED

ATC code: L01XC05

HSA approval date: 21 June 2021

Manufacturer(s): Wyeth Pharmaceutical Division of Wyeth Holdings LLC

Manufacturing country/countries: UNITED STATES

What are the HSA registration number and classification for MYLOTARG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 5MG/VIAL?

According to the HSA dataset updated 7 August 2026:

Registration number: SIN16243P

Classification: Prescription Only

Source for this answer

What active ingredients and strength are recorded for MYLOTARG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 5MG/VIAL?

According to the HSA dataset updated 7 August 2026:

Active ingredients: Gemtuzumab Ozogamicin

Strength: 5.0 mg/vial

Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.

Source for this answer

What dosage form and route are recorded for MYLOTARG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 5MG/VIAL?

According to the HSA dataset updated 7 August 2026:

Dosage form: POWDER, FOR SOLUTION

Route: INTRAVENOUS

Source for this answer

Who is the recorded registrant for MYLOTARG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 5MG/VIAL?

According to the HSA dataset updated 7 August 2026:

Registrant: PFIZER PRIVATE LIMITED

Source for this answer

Which manufacturers and countries are listed for MYLOTARG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 5MG/VIAL?

According to the HSA dataset updated 7 August 2026:

Manufacturer(s): Wyeth Pharmaceutical Division of Wyeth Holdings LLC

Manufacturing country/countries: UNITED STATES

Source for this answer

Where can I look up MYLOTARG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 5MG/VIAL in the HSA register?

Open HSA’s therapeutic product register and search for registration number SIN16243P or the exact product name MYLOTARG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 5MG/VIAL. The general register link does not preselect this product.

Source for this answer

What are the source dates for this MYLOTARG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 5MG/VIAL record?

This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.

The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.

Source for this answer

Has this MYLOTARG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 5MG/VIAL record had a separate HSA register check?

No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.

Search the HSA register using SIN16243P for the latest record.

Source for this answer

Sources and dates

HSA dataset: 2026. Updated: 13 November 2026.

Factual product information only; no dosing, treatment or suitability advice.

Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.

bottom of page